Signaturefd LLC Buys 288 Shares of Cardinal Health, Inc. (NYSE:CAH)

Signaturefd LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 12.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,532 shares of the company’s stock after acquiring an additional 288 shares during the period. Signaturefd LLC’s holdings in Cardinal Health were worth $255,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Lindbrook Capital LLC raised its stake in shares of Cardinal Health by 23.7% in the fourth quarter. Lindbrook Capital LLC now owns 945 shares of the company’s stock valued at $95,000 after purchasing an additional 181 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new position in shares of Cardinal Health in the 4th quarter valued at $616,000. Wetzel Investment Advisors Inc. bought a new position in shares of Cardinal Health during the 4th quarter worth about $36,000. Greenleaf Trust boosted its position in shares of Cardinal Health by 9.2% during the 4th quarter. Greenleaf Trust now owns 5,125 shares of the company’s stock valued at $517,000 after acquiring an additional 432 shares in the last quarter. Finally, Federated Hermes Inc. increased its stake in Cardinal Health by 5.8% in the fourth quarter. Federated Hermes Inc. now owns 267,941 shares of the company’s stock valued at $27,008,000 after acquiring an additional 14,606 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.6 %

Shares of CAH stock opened at $103.20 on Friday. The firm has a market capitalization of $25.10 billion, a price-to-earnings ratio of 40.63, a PEG ratio of 1.00 and a beta of 0.68. The firm’s 50 day moving average is $109.51 and its 200-day moving average is $104.67. Cardinal Health, Inc. has a 1 year low of $77.56 and a 1 year high of $116.04.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to the consensus estimate of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.32 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is 78.74%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CAH shares. SVB Leerink initiated coverage on Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 price objective on the stock. UBS Group upped their price target on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Argus raised Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. Finally, StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $103.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.